Search hospitals > Ohio > Cleveland
Hillcrest Hospital Cancer Center
Claim this profileCleveland, Ohio 44124
Global Leader in Cancer
Global Leader in Recurrence
Conducts research for Ovarian Cancer
Conducts research for Adenocarcinoma
Conducts research for Fallopian Tube Cancer
235 reported clinical trials
34 medical researchers
Summary
Hillcrest Hospital Cancer Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Adenocarcinoma, Fallopian Tube Cancer and other specialties. Hillcrest Hospital Cancer Center is involved with conducting 235 clinical trials across 280 conditions. There are 34 research doctors associated with this hospital, such as Peter Rose, MD, Nathan A. Pennell, Dale Shepard, and Aaron Gerds, MD, MS.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Recurrence
Global LeaderStage IV
Stage III
Stage I
Top PIs
Peter Rose, MDCleveland Clinic Foundation2 years of reported clinical research
Expert in Ovarian Cancer
Expert in Ovarian Tumors
25 reported clinical trials
50 drugs studied
Nathan A. PennellCleveland Clinic Foundation2 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Lung Cancer
16 reported clinical trials
25 drugs studied
Dale ShepardCleveland Clinic Foundation7 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
38 drugs studied
Aaron Gerds, MD, MSCleveland Clinic Foundation5 years of reported clinical research
Studies Myelofibrosis
Studies Primary Myelofibrosis
11 reported clinical trials
17 drugs studied
Clinical Trials running at Hillcrest Hospital Cancer Center
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Squamous Cell Carcinoma
Prostate Cancer
Diffuse Large B-Cell Lymphoma
Ovarian Cancer
Colorectal Cancer
Lymphoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Hillcrest Hospital Cancer Center?
Hillcrest Hospital Cancer Center is a medical facility located in Cleveland, Ohio. This center is recognized for care of Cancer, Recurrence, Ovarian Cancer, Adenocarcinoma, Fallopian Tube Cancer and other specialties. Hillcrest Hospital Cancer Center is involved with conducting 235 clinical trials across 280 conditions. There are 34 research doctors associated with this hospital, such as Peter Rose, MD, Nathan A. Pennell, Dale Shepard, and Aaron Gerds, MD, MS.